95 related articles for article (PubMed ID: 8817649)
21. Stable amplification of the S-adenosylmethionine decarboxylase gene in Chinese hamster ovary cells.
Kramer D; Mett H; Evans A; Regenass U; Diegelman P; Porter CW
J Biol Chem; 1995 Feb; 270(5):2124-32. PubMed ID: 7836441
[TBL] [Abstract][Full Text] [Related]
22. Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes.
Kaur K; Emmett K; McCann PP; Sjoerdsma A; Ullman B
J Protozool; 1986 Nov; 33(4):518-21. PubMed ID: 3098971
[TBL] [Abstract][Full Text] [Related]
23. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.
Porter CW; McManis J; Casero RA; Bergeron RJ
Cancer Res; 1987 Jun; 47(11):2821-5. PubMed ID: 3567905
[TBL] [Abstract][Full Text] [Related]
24. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
[TBL] [Abstract][Full Text] [Related]
25. The activator-binding site of Onchocerca volvulus S-adenosylmethionine decarboxylase, a potential drug target.
Ndjonka D; Zou Y; Bi X; Woster P; Walter RD; Lüersen K
Biol Chem; 2003 Aug; 384(8):1195-201. PubMed ID: 12974388
[TBL] [Abstract][Full Text] [Related]
26. Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion.
Singh S; Mukherjee A; Khomutov AR; Persson L; Heby O; Chatterjee M; Madhubala R
Antimicrob Agents Chemother; 2007 Feb; 51(2):528-34. PubMed ID: 17101681
[TBL] [Abstract][Full Text] [Related]
27. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
28. Correlation between inhibition of growth and arginine transport of Leishmania donovani promastigotes in vitro by diamidines.
Kandpal M; Tekwani BL; Chauhan PM; Bhaduri AP
Life Sci; 1996; 59(7):PL75-80. PubMed ID: 8761349
[TBL] [Abstract][Full Text] [Related]
29. Novel agmatine analogue, gamma-guanidinooxypropylamine (GAPA) efficiently inhibits proliferation of Leishmania donovani by depletion of intracellular polyamine levels.
Singh S; Jhingran A; Sharma A; Simonian AR; Soininen P; Vepsalainen J; Khomutov AR; Madhubala R
Biochem Biophys Res Commun; 2008 Oct; 375(1):168-72. PubMed ID: 18692480
[TBL] [Abstract][Full Text] [Related]
30. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
31. Combined action of inhibitors of S-adenosylmethionine decarboxylase with an antimalarial drug, chloroquine, on Plasmodium falciparum.
Das B; Gupta R; Madhubala R
J Eukaryot Microbiol; 1997; 44(1):12-7. PubMed ID: 9172828
[TBL] [Abstract][Full Text] [Related]
32. Effect of antioxidants on the growth and polyamine levels of Leishmania donovani.
Mukhopadhyay R; Madhubala R
Biochem Pharmacol; 1994 Feb; 47(4):611-5. PubMed ID: 8129739
[TBL] [Abstract][Full Text] [Related]
33. S-adenosylmethionine decarboxylase as an enzyme target for therapy.
Pegg AE; McCann PP
Pharmacol Ther; 1992 Dec; 56(3):359-77. PubMed ID: 1301596
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
35. New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity.
Regenass U; Caravatti G; Mett H; Stanek J; Schneider P; Müller M; Matter A; Vertino P; Porter CW
Cancer Res; 1992 Sep; 52(17):4712-8. PubMed ID: 1511437
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
37. The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylmethionine decarboxylase of Plasmodium falciparum: recombinant expression and catalytic properties of two different constructs.
Krause T; Lüersen K; Wrenger C; Gilberger TW; Müller S; Walter RD
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):287-92. PubMed ID: 11085920
[TBL] [Abstract][Full Text] [Related]
38. In vivo growth inhibition of L1210 leukemia by 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A), a new inhibitor of S-adenosylmethionine decarboxylase.
Dorhout B; Te Velde RJ; Ferwerda H; Kingma AW; De Hoog E; Muskiet FA
Int J Cancer; 1995 Apr; 61(2):214-7. PubMed ID: 7705950
[TBL] [Abstract][Full Text] [Related]
39. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
40. In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
Brun R; Bühler Y; Sandmeier U; Kaminsky R; Bacchi CJ; Rattendi D; Lane S; Croft SL; Snowdon D; Yardley V; Caravatti G; Frei J; Stanek J; Mett H
Antimicrob Agents Chemother; 1996 Jun; 40(6):1442-7. PubMed ID: 8726017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
